These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20100877)

  • 1. In vitro activity of ceftaroline against 623 diverse strains of anaerobic bacteria.
    Citron DM; Tyrrell KL; Merriam CV; Goldstein EJ
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1627-32. PubMed ID: 20100877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.
    Werth BJ; Rybak MJ
    Antimicrob Agents Chemother; 2014; 58(1):559-62. PubMed ID: 24217692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of ceftaroline against a broad spectrum of recent clinical anaerobic isolates.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2011 Jan; 55(1):421-5. PubMed ID: 21041506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
    Hamilton-Miller JM; Shah S
    Int J Antimicrob Agents; 1998 Nov; 10(4):321-4. PubMed ID: 9916909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin.
    Ednie L; Shapiro S; Appelbaum PC
    Diagn Microbiol Infect Dis; 2007 May; 58(1):133-6. PubMed ID: 17240107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of linezolid against anaerobic bacteria.
    Behra-Miellet J; Calvet L; Dubreuil L
    Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftaroline activity against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2009-2011).
    Pfaller MA; Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):422-8. PubMed ID: 24445158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftaroline: a new broad-spectrum cephalosporin.
    Lim L; Sutton E; Brown J
    Am J Health Syst Pharm; 2011 Mar; 68(6):491-8. PubMed ID: 21378297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of ceftaroline fosamil microbiology: integrated FOCUS studies.
    Critchley IA; Eckburg PB; Jandourek A; Biek D; Friedland HD; Thye DA
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii45-51. PubMed ID: 21482569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ertapenem: review of recent studies.
    Wexler HM
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011.
    Flamm RK; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):437-42. PubMed ID: 24582578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of TD-1792, a multivalent glycopeptide-cephalosporin antibiotic, against 377 strains of anaerobic bacteria and 34 strains of Corynebacterium species.
    Tyrrell KL; Citron DM; Warren YA; Goldstein EJ
    Antimicrob Agents Chemother; 2012 Apr; 56(4):2194-7. PubMed ID: 22290981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antimicrobial activity of a new cephalosporin, ceftaroline, and determination of quality control ranges for MIC testing.
    Brown SD; Traczewski MM
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1271-4. PubMed ID: 19114671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.